Zacks reiterated their neutral rating on shares of Regions Financial Corp (NYSE:RF) in a research report released on Monday morning. Zacks currently has a $11.00 price objective on the stock. Regions Financial Corporation (NYSE:RF)’s stock on 15 September traded at beginning with a price of $10.33 and when day-trade ended the stock finally decreased -0.68% to end at $10.28. Regions Financial Corporation (NYSE:RF)’s showed weekly performance of 1.78%.
A US federal court dismissed the ongoing antitrust lawsuit against Pfizer Inc. (NYSE:PFE) and India-based Ranbaxy Laboratories Limited (ADR) (RBXLY). The lawsuit, filed by retailers and distributors alleged both drug-makers of being involved in illegal agreements to prevent the generic version of Pfizer’s blockbuster cholesterol drug, Lipitor, from reaching the market. The drug’s patent expired in 2011.Pfizer Inc. (NYSE:PFE) on Monday closed at $29.92. Stock institutional ownership is 71.90% while insider ownership includes 0.02%. Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is 1.97%.
On Sep. 4, 2014 Aspen Insurance Holdings Limited (NYSE:AHL) announced that Stephen Postlewhite, previously Aspen’s Chief Risk Officer, has been appointed to the position of Chief Executive Officer of Aspen Re, the Company’s reinsurance business, with immediate effect. He succeeds James Few who is leaving Aspen to pursue other opportunities. Aspen Insurance Holdings Ltd. (NYSE:AHL)’s shares on Monday traded in the range of 42.05 – 42.59and ended up on $42.36. Aspen Insurance Holdings Ltd. (NYSE:AHL) distance from 200-day simple moving average (SMA200) is 2.01%. AHL’s sales growth for past 5 years was 6.10% and its EPS growth for past 5 years was 36.00%.
Inogen Inc (NASDAQ:INGN) disposed last September 9th through an open market transaction of 7,388 shares. These were sold at an average weighted price of $23.25, for a total value of $171,771. Following the filing, the filer indirectly owns 62,733 shares held by Versant Affiliates Fund II-A, L.P., 29,537 shares held by VSF II, and 3,306,680 held by VV II, amongst other small amounts also held by third parties. This is the first time this insider has reduced its exposure to the firm. Inogen, Inc. (NASDAQ:INGN)’s stock on 15 September decreased -8.15% to the closing price of $21.18. Its fifty two weeks range is $13.12 – 24.50. The total market capitalization recorded $386.3M. Inogen, Inc. (NASDAQ:INGN) monthly performance is 11.01%.
On 4 Sep Johnson & Johnson (NYSE:JNJ) said Thursday it is accelerating the development of a vaccine regimen against Ebola, in an effort to help curb the virus. Johnson & Johnson (NYSE:JNJ) on Monday closed at $104.72. Stock institutional ownership is 67.20% while insider ownership includes 0.02%. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average (SMA50) is 2.29%.